Finance

Lists
Why is B1Q down 5.16%?
Dive Deeper
B1Q:FRA
NRX Pharmaceuticals Inc
€2.48
-5.16%
(-0.13) 1D
Oct 1, 9:55:01 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for B1Q...
Open
€2.48
High
€2.48
Low
€2.48
Mkt. cap
126.42M
Avg. vol.
202.00
Volume
0.00
52-wk high
€4.12
52-wk low
€1.37
No. of employees
29
Open
€2.48
High
€2.48
Low
€2.48
Mkt. cap
126.42M
Avg. vol.
202.00
Volume
0.00
52-wk high
€4.12
52-wk low
€1.37
No. of employees
29
News stories
From web sources and news partners
About NRX Pharmaceuticals Inc
CEO-
Employees29
Founded2015
HeadquartersWilmington, Delaware, United States
SectorPharmaceutical industry
Websitenrxpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
242.00K
983.00K
1.07M
1.10M
Cost of goods sold
97.00K
408.00K
631.00K
675.00K
Cost of revenue
97.00K
408.00K
631.00K
675.00K
Research and development expenses
1.43M
558.00K
1.31M
2.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.81M
4.57M
3.81M
4.74M
Operating expense
4.26M
5.17M
5.18M
6.93M
Total operating expenses
4.36M
5.58M
5.82M
7.60M
Operating income
-4.12M
-4.59M
-4.75M
-6.50M
Other non operating income
-366.00K
1.59M
3.54M
-9.78M
EBT including unusual items
-5.89M
360.00K
-1.43M
-16.52M
EBT excluding unusual items
-4.48M
-3.67M
-1.44M
-16.52M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.89M
360.00K
-1.43M
-16.52M
Net profit margin
-2,433.88%
36.62%
-133.90%
-1,500.45%
Earnings per share
-0.51
0.18
-0.04
-0.24
Interest and investment income
2.00K
4.00K
5.00K
6.00K
Interest expense
-
-671.00K
-233.00K
-240.00K
Net interest expenses
2.00K
-667.00K
-228.00K
-234.00K
Depreciation and amortization charges
26.00K
42.00K
63.00K
66.00K
EBITDA
-4.11M
-4.55M
-4.68M
-6.43M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps